Showing results (271-280 of 329) with videos related to

Sort By:
Pageof 33
Urology|September 11, 2001
Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approachL G Luciani, E Neulander, W M Murphy, et al.
The Journal of Urology|September 25, 1997
Urogenital involvement by desmoplastic small round-cell tumorJ Furman, W M Murphy, Z Wajsman, et al.
Urology|October 1, 1985
Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer GroupW W Koontz, N M Heney, M S Soloway, et al.
Cancer|June 1, 1979
Occurrence of a thermostable antigen of ovarian carcinoma in normal tissues and secretionsR M Burton, T L McGrew, G H Barrows, et al.
The Journal of Urology|October 1, 1995
Quality of life: radical prostatectomy versus radiation therapy for prostate cancerA J Lim, A H Brandon, J Fiedler, et al.
European Urology|January 1, 1996
A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study GroupM S Soloway, P Schellhammer, R Sharifi, et al.
The Journal of Urology|May 24, 2001
Second opinion of anatomical pathology: a complex issue not easily reduced to matters of right and wrongW M Murphy, I Rivera-Ramirez, L G Luciani, et al.
The American Journal of Surgical Pathology|March 1, 1986
Incidental carcinoma of the prostate. How much sampling is adequate?W M Murphy, P J Dean, J A Brasfield, et al.
Cancer|December 15, 1981
Renal disease after mitomycin C therapyW T Hanna, S Krauss, R F Regester, et al.
Human Pathology|March 1, 1996
The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literatureP A Drew, W M Murphy, F Civantos, et al.
Pageof 33